Course Experts: Josh Zhang, PharmD; Eno Inyang, PharmD, BCPS, BCOP; Emily Tiao, PharmD, BCOP

Course Description: This course outlines the pathophysiology, diagnosis, and treatment of patients with Acute Promyelocytic Leukemia (APL), as well as reviews pertinent literature and patient considerations.

[DFCI_KEYWORDS] Chronic Lymphocytic Leukemia (CLL), Bruton’s Tyrosine Kinase (BTK) Inhibitors, Pathophysiology, Prognostic Markers, Genetic Markers, Cytogenetics, Ibrutinib, Acalabrutinib, Zanubrutinib, Pirtobrutinib, Lymphocytes, Lymphadenopathy, Venetoclax, Obinutuzumab, Rituximab, Fludarabine, Bendamustine, Antiplatelet, Anticoagulation, Leukocytosis